Combat Medical highlights patient impact of HIVEC HEAT trial at the American Urological Association Annual Meeting
MHRA-approved phase 3 study is investigating intravesical delivery of hyperthermic chemotherapy in bladder-sparing treatment of patients with non-muscle invasiv...















